In an interview with Consultant360, Kathryn Kreider, DNP, APRN, FAANP, FNP-BC, talks about how health care providers can discuss GLP-1 receptor agonists with patients and provide them with accurate information about medications for type 2 diabetes and obesity. When talking to your patients about these medications, do you find that your patients refer to common “myths” regarding these medications?